Pendium

Step 1 of 9

Noom owns the psychology-based weight loss conversation in AI answers, but clinical competitors are closing in.

Below is the snapshot of where Noom is the clear leader, and where newer medical telehealth brands are beginning to split the recommendation.

Noom's baseline score
82/100
Excellent

Noom is a category leader with high AI visibility driven by deep editorial coverage and academic citations. The brand is successfully pivoting to be the go-to recommendation for medical weight loss paired with behavioral coaching.

What we see
  • Noom has an exceptional citation footprint in mainstream media (Forbes, Wirecutter) and academic journals, making it a 'canonical' recommendation for AI agents.
  • The brand's move into GLP-1 medications (Noom Med) is already being picked up by AI assistants as a differentiator against legacy apps.
  • There is a growing volume of 'cheaper alternative' content on the web that specifically targets Noom, which AI agents are starting to surface.
  • AI assistants like Welli are helping Noom build a moat of proprietary, AI-ready data that external agents cannot easily replicate.
  • High Trustpilot volume (66k+ reviews) serves as a critical trust signal that AI Overviews and Gemini heavily weight.
Business goals Noom is likely trying to hit
  • Maintain market dominance in the behavior-change category while expanding into clinical GLP-1 care
  • Increase retention by leveraging AI-powered personalization and companion tools
  • Scale B2B partnerships with employers and health plans as a 'personalized health OS'
  • Counteract the growth of lower-cost AI tracking competitors like CalorieScan AI